Superbug infections resistant to multiple antibiotics kill around 33,000 people a year in Europe, health experts said on Monday, and the burden of these diseases is comparable to that of flu, tuberculosis and HIV combined.
(Reuters Health) - Young children who had surgery under general anesthesia were no more likely than their siblings who weren't exposed to anesthesia to experience developmental challenges that impair school readiness, a Canadian study found.
The World Health Organization is releasing more than a million doses of yellow fever vaccine from its emergency stockpile after the deadly mosquito-borne disease killed 10 people in southwestern Ethiopia, a WHO report said on Monday.
(Reuters Health) - A preliminary study suggests that a new skin sensor could help avoid life-threatening crises for the millions of people living with hydrocephalus, a condition that causes fluid to accumulate in the brain.
France's health safety watchdog Anses ordered a ban on products containing metam sodium, widely used in vegetable farming, on Monday after several people fell ill, saying it poses a risk to human health and the environment.
Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people with type 2 diabetes, according to results of a large clinical trial.
Novartis International AG said on Friday that its Sandoz division is abandoning an effort to gain U.S. regulatory approval for a biosimilar of rituximab, a medication used to treat certain cancer and rheumatoid arthritis.
Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.
An advisory panel to the U.S. Food and Drug Administration on Friday recommended Sage Therapeutics Inc's experimental treatment for postpartum depression, saying the benefits of the drug outweighed risks.
The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.
(Reuters Health) - People with insomnia who receive a digitized version of cognitive behavioral therapy (CBT) as part of their treatment may find more symptom relief than those who only receive tips to improve their sleep routines, a recent experiment suggests.